All Posts: News Release
-
Boosting Stem Cell Activity Can Enhance Immunotherapy Benefits
WASHINGTON (November 23, 2020) — Immune-system T cells have been reprogrammed into regenerative stem cell-like memory (TSCM) cells that are long-lived, highly active “super immune cells” with strong antitumor activity, according to new research from Georgetown Lombardi Comprehensive Cancer Center. The reprogramming involves a novel approach the researchers developed that inhibits the activity of proteins […]
Category: News Release
-
Immunotherapy Combo Halts Rare, Stage 4 Sarcoma in Teen
NUTLEY, NJ (October 14, 2020) — A patient with end-stage and rapidly progressing soft-tissue cancer whose tumor did not respond to standard treatment had a “rapid and complete response” to a novel combination of immunotherapy, according to new research published by a team of scientists from John Theurer Cancer Center at Hackensack University Medical Center […]
Category: News Release
-
Menthol Cigarette Ban in the U.S. May Lower Number of Smokers
Category: News Release
-
Georgetown Lombardi Launches COVID-19 Antibody Study in People with Cancer
WASHINGTON (April 29, 2020) — Georgetown Lombardi Comprehensive Cancer Center, in collaboration with MedStar Georgetown University Hospital, has begun a study to test for specific virus antibodies in people with cancer, who are vulnerable to COVID-19. The FDA, has approved (under an emergency use authorization) only a few tests produced commercially to detect antibodies against […]
Category: News Release
-
Adding Smoking Cessation to Lung Cancer Screening Can Reduce Mortality by 14%
WASHINGTON (March 9, 2020) — Including smoking cessation with existing lung cancer screening efforts would reduce lung cancer mortality by 14 percent and increase life-years gained by 81 percent compared with screening alone, according to a study led by researchers at the University of Michigan and Georgetown Lombardi Comprehensive Cancer Center. The study is published […]
Category: News Release
-
Gut Bacteria May Be One Culprit for Increase of Colorectal Cancer in Younger People
SAN FRANCISCO (January 21, 2020) — A bacteria typically linked to periodontal disease, Fusobacterium nucleatum (F. nuc), could play an important role in the rising incidence of colorectal cancer in people under the age of 45. Another type of bacteria, Moraxella osloensis, has been found in colorectal cancer tumors at a nearly four-fold higher rate […]
Category: News Release
-
New Drug Prevents Liver Damage, Obesity and Glucose Intolerance in Mice on High-Fat Diet
WASHINGTON (January 21, 2020) — Mice given a new drug targeting a key gene involved in lipid and glucose metabolism could tolerate a high-fat diet regimen (composed of 60% fat from lard) without developing significant liver damage, becoming obese, or disrupting their body’s glucose balance. The study by Georgetown Lombardi Comprehensive Cancer Center researchers appeared […]
Category: News Release
-
Neurologic Drug Combined with Blood Pressure Medicine Reduces Breast Tumor Development in Mice
WASHINGTON (December 30, 2019) — Adding a medication used to treat epilepsy, bipolar disorder and migraines to a blood pressure medicine reversed some aspects of breast cancer in the offspring of mice at high risk of the disease because of the high-fat diet fed to their mothers during pregnancy. Conversely, this treatment combination increased breast […]
Category: News Release
-
Georgetown Lombardi Comprehensive Cancer Center and Hackensack Meridian Health Join New York Genome Center as Associate Members
EDISON, N.J., (December 19, 2019) — The Georgetown Lombardi Comprehensive Cancer Center consortium and Hackensack Meridian Health have become the newest institutional associate members of the New York Genome Center (NYGC), an independent and non-profit academic research institution focused on furthering genomic research. The two institutions join through two separate partnerships using advanced DNA analysis to […]
Category: News Release
-
Palbociclib is Safe for Women with Advanced Breast Cancer Who Have Unique Gene Alteration
WASHINGTON (December 11, 2019) — Women who receive palbociclib (Ibrance®) to treat their advanced breast cancer and have a gene alteration that can lead to a condition known as benign ethnic neutropenia (BEN) can safely receive the drug without major concerns of developing infections associated with neutropenia, or low white blood cell counts, say Georgetown Lombardi […]
Category: News Release